Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filedfiledCritical
Priority to ECSP982802priorityCriticalpatent/ECSP982802A/en
Publication of ECSP982802ApublicationCriticalpatent/ECSP982802A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se revela una forma de dosificación sólida administrable oralmente que contiene una composición de rivabirina compactada que tiene uan densidad de batido elevada de por lo menos 0,6 g/mL, como asi también velocidades de desintegración y disolución sorprendentemente rápidas y donde la ribabirina está sustancialmente libre de forma polimórficas de rivabirina y un proceso para realizar dichas formas de dosificación sólidas.An orally administrable solid dosage form is disclosed containing a compacted rivabirin composition having a high churning density of at least 0.6 g / mL, as well as surprisingly fast disintegration and dissolution rates and where ribabirin is substantially polymorphic free of rivabirin and a process for making such solid dosage forms.
ECSP9828021998-12-211998-12-21
ORIGINALLY ADMINISTRABLE SOLID RIBAVIRIN DOSAGE FORMS AND PROCESS TO PERFORM THEM
ECSP982802A
(en)